Macrophage protein turnover. Evidence for lysosomal participation in basal proteolysis.
1. Turnover of intracellular proteins in cultured mouse macrophages was found to be slightly accelerated by the omission of serum from the culture medium. Media containing 10% (v/v) or more of serum established basal degradation rates in the cultures. 2. Basal degradation rates varied considerably between experiments, probably as a result of variable activation in vivo of the macrophages. 3. The selective carboxyl proteinase inhibitor pepstatin, which appeared to enter the lysosomes of the cells by pinocytosis, gave a progressive inhibition of basal proteolysis up to a maximum of about 40%. Cellular cathepsin D was largely inhibited after 48h of cultivation with pepstatin (100 micrograms/ml). 4. Leupeptin and 7-amino-1-chloro-3-tosylamidoheptan-2-one are less selective proteinase inhibitors. They also induced 25--35% inhibition of degradation, but their actions may not have been restricted to lysosomes. 5. Several solutes and particles that are endocytosed by macrophages and stored in lysosomes induce some inhibition of basal proteolysis, whether or not they themselves are substrates for proteolysis. 6. Colchicine was without effect on protein degradation, but cytochalasin B and the local anesthetics lidocaine and procaine, all of which have effects on microfilaments, were significantly inhibitory. This inhibition may result from a decrease in the rate of autophagy, and thus of lysosomal proteolysis, due to prevention of microfilament action.
D000818:Animals; D002478:Cells, Cultured; D004705:Endocytosis; D007700:Kinetics; D008247:Lysosomes / Q000378:metabolism; D008264:Macrophages / Q000187:drug effects / Q000378:metabolism*; D051379:Mice; D010537:Peritoneum / Q000378:metabolism; D011480:Protease Inhibitors / Q000494:pharmacology; D011506:Proteins / Q000378:metabolism*
D011480:Protease Inhibitors; D011506:Proteins